EU GMP Annex 11 Draft: What Is Changing
and How It Will Impact Computerized Systems
The EU GMP Annex 11 draft revision (2025) introduces a major modernization of expectations for computerized systems in regulated industries. It focuses on stronger lifecycle management, risk-based validation, supplier oversight, data integrity, and the control of modern technologies such as cloud platforms and AI-enabled systems.
Companies will need to demonstrate that their validation and governance approaches can control modern digital environments, including SaaS platforms, hybrid architectures, and continuously updated systems.
Why Annex 11 Is Being Revised
Annex 11 was last updated in 2011, when the technological landscape looked different.
At that time:
- Cloud adoption was limited.
- SaaS platforms were rare in regulated environments.
- Artificial intelligence was not embedded in operational systems.
Today, digital infrastructure has become central to pharmaceutical and life sciences operations.
The 2025 draft revision aims to align GMP expectations with the current technological reality.
This includes:
- cloud and SaaS environments.
- integrated digital systems.
- modern software development practices.
- increased reliance on external system providers.
Regulators are effectively saying:
“If your systems evolve, your control over them must evolve as well.”
What Are the Main Changes in the Annex 11 Draft?
1. Stronger Lifecycle Control of Computerized Systems
Validation is expected to follow a continuous lifecycle approach rather than a one-time project.
Companies must demonstrate control over:
System implementation
Configuration management
System updates
Integration between systems
Long-term system monitoring
This aligns with modern validation practices based on lifecycle management and continuous oversight.
2. Greater Focus on Supplier and Vendor Oversight
Modern systems are often developed and maintained by external providers.
This means companies must demonstrate effective governance of suppliers.
Expected controls include:
- vendor qualification processes.
- supplier audits.
- quality agreements.
- transparency regarding software development and updates.
Organizations remain responsible for compliance even when using third-party systems.
3. Increased Emphasis on Data Integrity
Data integrity continues to be one of the most critical regulatory concerns.
Companies must ensure:
- reliable audit trails.
- traceability of system activities.
- protection against unauthorized data manipulation.
- controlled data lifecycle management.
Regulators expect organizations to prove that critical data remains accurate and secure throughout its lifecycle.
4. Stronger Risk-Based Validation Expectations
The draft reinforces the concept that validation must be risk-based and proportional.
Instead of applying identical validation approaches to all systems, companies must demonstrate that validation efforts correspond to the level of risk to:
This approach aligns closely with GAMP® 5 principles and modern validation frameworks.
How This Will Impact Life Sciences Companies
Many organizations still apply validation approaches designed for traditional on-premises systems.
However, these methods struggle with modern digital environments that involve:
- agile software development.
- continuous system updates.
- cloud platforms.
- distributed architectures.
As a result, companies often face challenges such as:
- excessive documentation.
- slow validation cycles.
- limited traceability.
- inefficient change management
The Annex 11 revision signals that validation approaches must evolve.
How Companies Should Start Preparing
Even before the final regulation is published, organizations can take initiative and take steps.
Review validation strategies: move away from document-heavy validation models toward risk-based lifecycle approaches.
Strengthen supplier management: ensure that vendors can demonstrate transparent development and quality processes.
Improve system governance: establish controls for system configuration, updates, and integrations.
Prepare for AI and advanced digital systems: future regulatory expectations will address AI-enabled systems and advanced automation.
The Knowledge Gap in Modern Validation
One of the biggest challenges organizations face today is not technology.
It is capability and knowledge.
Many professionals were trained using validation models that do not address modern digital environments.
Learn How to Apply Modern Validation Approaches
If you want to go beyond theory and learn how to apply modern validation strategies in practice, structured training is essential.
The FIVE Academy was created to help professionals and organizations understand how to implement validation approaches that work in modern digital environments.
Many professionals read Annex 11, FDA 21 CFR Part 11, FDA CSA, or GAMP® 5, but still struggle with questions such as:
- What validation activities are expected?
- How should risk and testing be structured?
- How do these expectations apply to modern digital systems?
At FIVE Academy, we focus on translating regulatory expectations into simple, practical validation approaches that can be applied to any computerized system.
We break down the lifecycle and explain what regulators expect at each stage, helping professionals move from theory to implementation.
Accelerating Compliance with GO!FIVE® Digital Validation Tool
At FIVE Validation, we developed GO!FIVE®, a digital validation platform designed to simplify and structure the validation lifecycle for modern computerized systems.
Instead of starting validation from scratch, the platform provides pre-structured validation intelligence, including:
- Requirement scenario suggestions.
- Risk scenario libraries.
- Test scenario templates.
These scenarios are aligned with major regulatory expectations, including:
- EU GMP Annex 11.
- FDA 21 CFR Part 11.
- Data Integrity principles.
- GAMP® 5 risk-based validation concepts.
In addition, the platform includes scenarios for various systems and processes, helping teams accelerate validation while maintaining compliance.
This approach enables organizations to:
- reduce validation effort.
- standardized validation practices.
- improve traceability.
- scale validation across digital systems.
Instead of reinventing validation strategies for each system, teams can leverage a structured digital validation framework designed for modern regulated environments.
Watch the Full Webinar
If you would like a deeper understanding of the Annex 11 draft revision and its practical implications, you can also watch the full webinar presentation.
In the session, we explored:
- What is changing in the Annex 11 draft?
- How the revision affects computerized systems.
- The practical implications for validation and data integrity.
- How can companies start preparing now?
Frequently Asked Questions
GAMP5® is a guide whose intellectual property is reserved by ISPE®. Available for purchase at https://ispe.org/.
Note: This article was developed based on the draft revision of EMA Annex 11. You can access the document here: access here.
About the author:
Lílian Ribeiro is a chemical engineer, biomedical systems technologist, postgraduate in Integrated Management Systems, and Data Science and Business Analytics. She has over a decade of technical and commercial experience in the food, pharmaceutical, and healthcare industries. As an advocate for paperless validation, Lilian is passionate about introducing efficiency and innovation into life sciences companies. Her vast experience is fundamental in validation and qualification projects, encompassing digital validation, ERP, EQMS, automation (PW) and IT infrastructure qualification.
About the reviewer:
Silvia is Brazilian electrical engineer and entrepreneur with over 23 years of experience in the Life Sciences industry, working mainly in the biotechnology, pharmaceutical, medical device, and cosmetics sectors. She has an international background with specialized training in GAMP5® and FDA 21 CFR Part 11 in England, SAP® validation in Germany, and data integrity and governance in Denmark. Lives in the Netherlands, Silvia serves as the CEO and co-founder of FIVE Validation, a company dedicated to simplifying regulatory compliance. She is the visionary behind GO!FIVE®, the digital validation platform, and is also responsible for the content of the FIVE Academy training platform. Her work focuses on accelerating and optimizing processes with robustness, traceability, and compliance, supporting companies in integrating the ESG culture, particularly in the Social (S) and Governance (G) pillars. Beyond her corporate role, Silvia is available to connect companies from anywhere in the world with the Pastoral do Menor de Sorocaba, in São Paulo state, Brazil, an institution aligned with the United Nations’ Sustainable Development Goals (SDGs) and recognized for its social impact, benefiting more than 1,400 children and adolescents in vulnerable situations every day.